Feldman et al.
produced 21 mg of 38h (24%) and 30 mg of 39h (34%). 38h:
2H, J ) 7.4 Hz), 2.07 (s, 3H), 2.02 (s, 3H), 0.93 (s, 9H), -0.02 (s,
6H); 13 C NMR (C6D6) δ ppm: 145.0, 136.1, 130.9, 126.0, 121.8, 120.8,
119.6, 110.5, 110.4, 63.3, 29.4, 27.5, 26.1, 18.1, 9.9, 9.7, -5.4; ES+
m/z (relative intensity) 342.2 (M + H, 100%); HRMS (ES+) calcd
for C21H32NOSi: 342.2253, found 342.2253.
1
(yellow oil): IR (neat): 3401 cm-1; H NMR (400 MHz, C6D6) δ
7.81 (d, J ) 7.4 Hz, 1H), 7.26 (t, J ) 7.0 Hz, 1H), 7.21 (m, 2H),
6.73 (br s, 1H), 6.28 (s, 1H), 4.06 (dd, J ) 9.1, 7.2 Hz, 1H), 3.75
(t, J ) 7.1 Hz, 1H), 3.62 (t, J ) 8.7 Hz, 1H), 1.84 (s, 3H), 1.00 (s,
9H), 0.05 (s, 3H), 0.02 (s, 3H); 13C NMR (90 MHz, C6D6) δ 147.5,
140.4, 134.5, 132.9, 125.6, 122.4, 120.6, 120.3, 119.4, 112.2, 65.3,
48.5, 26.2, 18.6, 13.2, -5.1, -5.3; ES+ m/z (relative intensity)
314.2 (M + H), 100%); HRMS (ES+) calcd for C19H28NOSi:
314.1940, found 314.1944.
6,9,9-Trimethyl-5,7,8,9,10,10a-hexahydro-indeno[2,1-b]indol-
10-ol (42a) and 3,3,1,1-Trimethyl-2,3-dihydro-1H-indolo[1,2-
a]indole (44). Method A: Following general procedure 4, 109 mg
(0.369 mmol) of allene 29 produced 59 mg (60%) of 42a as a brown
solid. Method B: Following general procedure 5, 350 mg (1.18
mmol) of allene 29 produced 107 mg (34%) of 42a as a brown
solid and 72 mg (25%) of 441b as a brown solid. Method C:
Following general procedure 6, 78 mg (0.26 mmol) of allene 29
produced 15 mg (21%) of 42a as a brown solid and 16 mg (24%)
of 44 as a brown solid. 42a: mp. 76 °C (dec.); IR (neat): 3400,
1
(39 h). (yellow oil): H NMR (400 MHz, C6D6) δ 7.75 (d, J )
7.7 Hz, 1H), 7.47 (d, J ) 8.0 Hz, 1H), 7.25 (t, J ) 7.2 Hz, 1H),
7.19 (t, J ) 7.6 Hz, 1H), 6.28 (s, 1H), 5.79 (s. 1H), 4.48 (t, J )
6.0 Hz, 1H), 3.78 (dd, J ) 10.0, 6.0 Hz, 1H), 3.48 (dd, J ) 10.0,
6.0 Hz, 1H), 1.87 (s, 3H), 0.89 (s, 9H), -0.05 (s, 3H), -0.12 (s,
3H); 13C NMR (100 MHz, C6D6) δ 148.5, 135.4, 133.7, 129.9,
122.1, 121.5, 119.6, 110.5, 90.9, 65.2, 64.3, 26.0, 18.4, 12.4, -5.3,
-5.6; ES+ m/z (relative intensity) 314.2 (M + H, 100%), 627.4
(2 M + H, 25%); HRMS (ES+) calcd for C19H28NOSi: 314.1940,
found 314.1951.
1
3301 cm-1; H NMR (400 MHz, C6D6) δ 7.94 (d, J ) 7.7 Hz,
1H), 7.29 - 7.20 (m, 3H), 6.99 (br s, 1H), 3.26 (d, J ) 10.7 Hz,
1H), 2.56 (dd, J ) 10.7, 4.8 Hz, 1H), 2.34 (dd, J ) 14.2, 3.0 Hz,
1H), 2.16 (td, J ) 14.2, 3.2 Hz, 1H), 1.80 - 1.75 (m, 1H), 1.77 (s,
3H), 1.44 (dd, J ) 13.1, 3.2 Hz, 1H), 1.08 (s, 3H), 1.08 - 0.99 (m,
1H), 0.91 (s, 3H); 13C NMR (90 MHz, CDCl3) δ 148.9, 145.5,
139.3, 125.0, 122.5, 120.7, 120.1, 119.5, 118.3, 111.8, 82.6, 49.1,
40.7, 36.2, 28.0, 22.7, 17.5, 10.2; APCI+ m/z (relative intensity)
268.2 (M + H, 100%); HRMS (ES+) calcd for C18H22NO:
268.1701, found 268.1714.
1-(tert-Butyl-dimethyl-silanyl)-3-methyl-1,4-dihydro-cyclo-
penta[b]indole (38i) and 3-(tert-Butyl-dimethyl-silanyl)-1-meth-
yl-8H-3a-aza-cyclopent[a]indene (40i). Method A: Following
general procedure 4, with column chromatography performed at
-78 °C, 84 mg (0.27 mmol) of allene 25 produced 34 mg (44%)
of 38i as a yellow oil. Method B: Following general procedure 5,
75 mg (0.23 mmol) of allene 25 produced 22 mg (34%) of 38i as
a yellow oil. Method B: Following general procedure 6, 1005 mg
(0.30 mmol) of allene 25 produced 21 mg (25%) of 38i as a yellow
oil and 7.4 mg (9%) of 40i as a light yellow oil. 38i: IR (neat):
4-(tert-Butyl-dimethyl-silanyloxy)-3,3-dimethyl-11-trimethyl-
silanylmethyl-2,3,4,4a-tetrahydro-1H-indolo[1,2-a]indole (43e)
and 2-{1-[3-(tert-Butyl-dimethyl-silanyloxy)-4,4-dimethyl-cyclo-
hex-1-enyl]-vinyl}-1H-indole (45e). Method A: Following General
Procedure 5, 135 mg (0.28 mmol) of 28e produced 45 mg (35%)
of 43e as a white solid and 44 mg (41%) of 45e as a brown oil.
Method B: Following General Procedure 6, 60 mg (0.12 mmol) of
28e produced 28 mg (50%) of 43e as a white solid and 5 mg (11%)
of 45e as a brown oil. Crystals of 43e suitable for X-ray
crystallographic analysis were obtained by slow evaporation of an
Et2O/hexanes solution of 43e over a period of 24 h at rt. mp. 105
- 106 °C. 43e: IR (neat): 1456 cm-1; 1H NMR (300 MHz, CDCl3)
δ 7.49 (m, 2H), 7.00 (m, 2H), 6.08 (s, 1H), 4.55 (d, J ) 9.3 Hz,
1H), 3.10 (d, J ) 9.4 Hz, 1H), 2.48 (dd, J ) 14.2, 5.5 Hz, 1H),
2.31 (td, J ) 12.9, 5.1 Hz, 1H), 1.87 (s, 2H), 1.63 (dd, J ) 13.4,
4.0 Hz, 1H), 1.33 (m, 1H), 1.15 (s, 3H), 1.00 (s, 12H), 0.06 (s,
9H), -0.06 (s, 3H), -0.84 (s, 3H); 13C NMR (75 MHz, CDCl3) δ
151.3, 139.6, 137.0, 132.3, 125.0, 120.7, 119.7, 118.8, 112.3, 90.8,
84.1, 65.6, 39.1, 37.8, 29.9, 26.6, 22.7, 18.5, 18.4, 15.5, -0.9, -2.3,
-3.7; ES+ m/z (relative intensity) 454.3 (M + H, 100%); HRMS
(ES+) calcd for C27H44NOSi2: 454.2961, found 454.2949.
1
3410 cm-1; H NMR (360 MHz, CDCl3) δ 7.95 (br s, 1H), 7.57
(m, 1H), 7.37 (m, 1H), 7.07 (m, 2H), 6.35 (app pent, J ) 1.8 Hz,
1H), 3.43 (app pent, J ) 1.8 Hz, 1H), 2.21 (t, J ) 1.8 Hz, 3H),
0.87 (s, 9H), 0.24 (s, 3H), -0.36 (s, 3H);13C NMR (75 MHz,
CDCl3) δ 147.6, 140.3, 133.2, 127.9, 124.6, 123.2, 119.9, 119.3,
119.2, 111.7, 38.0, 27.3, 18.0, 12.8, -4.5, -8.1; MS (ES+) m/z
(relative intensity) 284.2 (M + H, 90%), 567.4 (2 M + H, 100%),
850.6 (3 M + H, 25%); HRMS (ES+) calcd for C18H26NSi:
284.1835, found 284.1837.
40iIR (neat): 2123, 1606 cm-1; 1H NMR (360 MHz, C6D6) δ ppm:
7.68 (d, 1H, J ) 8.3 Hz), 7.21 (s overlap w solvent, 1H), 7.11 (d, 1H,
J) 7.6 Hz), 6.74 (s, 1H), 3.34 (s, 2H), 2.18 (s, 3H), 1.11 (s, 9H), 0.50
(s, 6H); 13C NMR (90 MHz, C6D6) δ ppm: 143.5, 138.7, 135.6, 127.1,
126.1, 122.4, 122.4, 121.0, 111.9, 111.6, 27.6, 27.4, 18.2, 11.1, -3.1;
MS (ES+) m/z (relative intensity) 284.2 (M + H, 100%); HRMS
(ES+) calcd for C18H26NSi: 284.1835, found 284.1816.
1-[2-(tert-Butyl-dimethyl-silanyloxy)-ethyl]-2,3-dimethyl-1,4-
dihydro-cyclopenta[b]indole (38m) and 3-[2-(tert-Butyl-dimeth-
yl-silanyloxy)-ethyl]-1,2-dimethyl-8H-3a-aza-cyclopenta[a]in-
dene (40m). Method A: Following general procedure 4, with
column chromatography performed at -78 °C and irradiation
performed at 350 nm, 75 mg (0.20 mmol) of allene 24 produced
29 mg (42%) of 38m as a yellow oil. Method B: Following general
procedure 5, with column chromatography on deactivated silica gel
(2% H2O/SiO2), 100 mg (0.27 mmol) of allene 24 produced 6 mg
(7%) of 38m as a yellow oil and 37 mg (40%) of 40m as a colorless
45e: IR (neat): 3412 cm-1; 1H NMR (300 MHz, CDCl3) δ 8.05
(br s, 1H), 7.56 (dd, J ) 8.2, 1.1 Hz, 1H), 7.31 (dd, J ) 8.0, 0.8
Hz, 1H), 7.16 (td, J ) 7.0, 1.2 Hz, 1H), 7.08 (td, J ) 7.1, 1.2 Hz,
1H), 6.52 (dd, J ) 2.1, 0.9 Hz, 1H), 5.79 (pent, J ) 1.6 Hz, 1H),
5.34 (s, 1H), 5.22 (s, 1H), 3.88 (dd, J ) 4.9, 2.0 Hz, 1H), 2.25 (m,
2H), 1.65 (m, 1H), 1.45 (m, 1H), 0.96 (s, 3H), 0.92 (s, 3H), 0.90
(s, 9H), 0.05 (s, 3H), 0.00 (s, 3H); 13C NMR (75 MHz, CDCl3) δ
142.3, 137.4, 136.4, 136.0, 131.2, 128.6, 122.2, 120.6, 119.9, 111.9,
110.6, 102.4, 74.7, 33.8, 33.3, 26.8, 25.9, 25.4, 21.4, 18.2, -4.1,
-4.9; ES+ m/z (relative intensity) 382.2 (M + H, 100%); HRMS
(ES+) calcd for C24H36NOSi: 382.2566, found 382.2555.
1
oil. 38m: IR (neat): 3401 cm-1; H NMR (300 MHz, CDCl3) δ
7.94 (br s, 1H), 7.53 (d, J ) 7.7 Hz, 1H), 7.34 (dd, J ) 7.0, 0.9
Hz, 1H), 7.08 (td, J ) 7.1, 0.9 Hz, 1H), 7.01 (t, J ) 7.2 Hz, 1H),
3.83 - 3.71 (m, 2H), 3.34 - 3.31 (m, 1H), 2.35 - 2.24 (m, 1H), 2.03
(d, J ) 1.0 Hz, 3H), 2.01 (d, J ) 0.7 Hz, 3H), 1.60 - 1.55 (m, 1H),
0.89 (s, 9H), 0.04 (s, 3H), 0.02 (s, 3H);13C NMR (90 MHz, CDCl3)
δ 148.4, 145.5, 139.3, 125.0, 124.1, 120.7, 119.9, 119.2, 117.9,
111.7, 61.4, 44.7, 33.9, 26.0, 18.3, 12.9, 10.4, -5.15, -5.22; ES+
m/z (relative intensity) 342.2 (M + H, 100%); HRMS (AP+) calcd
for C21H32NOSi: 342.2253, found 342.2239.
6,9,9-Trimethyl-10-(2-trimethylsilanyl-ethoxymethoxy)-
5,7,8,9,10,10a-hexahydro-indeno[2,1-b]indole (42f) and 3,3,1,1-
Trimethyl-2,3-dihydro-1H-indolo[1,2-a]indole (44). Method A:
Following general procedure 4, 84 mg (0.20 mmol) of allene 28c
produced 47 mg (60%) of 42f as a yellow solid. Method B:
Following general procedure 5, 67 mg (0.16 mmol) of allene 28c
produced 22 mg (35%) of 42f as a yellow solid and 20 mg (51%)
of 441b as a yellow solid. Method C: Following general procedure
6, 57 mg (0.13 mmol) of allene 28c produced 20 mg (38%) of 42f
as a yellow solid and 17 mg (51%) of 44 as a yellow solid.42f:
40m: IR (neat): 2857, 1607, 1098 cm-1; 1H NMR (300 MHz, C6D6)
δ ppm: 7.32 (d, 1H, J ) 3.9 Hz), 7.05 (t, 2H, J ) 7.0 Hz), 6.86 (dt,
1H, J ) 3.7, 0.9 Hz), 3.81 (t, 2H, J ) 7.5 Hz), 3.32 (bs, 2H), 3.13 (t,
1
mp. 139 - 140 °C; IR (neat): 3405 cm-1; H NMR (400 MHz,
CDCl3) δ 7.99 (br s, 1H), 7.55 (d, J ) 7.8 Hz, 1H), 7.32 (d, J )
4972 J. Org. Chem. Vol. 74, No. 14, 2009